Discover 700 paid clinical trials in Oklahoma. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Oklahoma offers many options for individuals interested in paid research studies as both healthy participants and those with specific health conditions. Leading research centers in Oklahoma City, Tulsa, and Norman are recruiting volunteers, giving access to the latest treatments and specialized care.
Filter
1
Filter results
Results: 700
A Study of NX-1607 in Adults With Advanced Malignancies
for
Ovarian Cancer, Epithelial, Gastric Cancer,
Location: Charlottesville VA, Chapel Hill NC, Chicago IL,
Sponsor: Nurix Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT05107674
Phase 1, Recruiting
A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
Location: Boston MA, Providence RI, Camden NJ, Doylestown PA,
Sponsor: Genmab
Sex: All
Age: 18+
Code: NCT05579366
Phase 1, Phase 2, Recruiting
JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC
for
Carcinoma, Squamous Cell
Location: Boston MA, The Bronx NY, Staten Island NY,
Sponsor: Johnson & Johnson Enterprise Innovation Inc.
Sex: All
Age: 60+
Code: NCT04892173
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
The Effect of NAD Supplementation on Brain Vascular Health in Aging
for
Aging
Location: Oklahoma City OK
Sponsor: University of Oklahoma
Sex: All
Age: 60 - 70+
Code: NCT05483465
Recruiting
A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]
for
Myositis
Location: Boston MA, New York NY, Miami FL, Plantation FL,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT05895786
Phase 3, Recruiting
A Study to Evaluate Lenti-HPV-07 Immunotherapy Against HPV+ Cervical or Oropharyngeal Cancer
for
HPV-Related Cervical Carcinoma,
Location: Orlando FL, Tampa FL, Tulsa OK
Sponsor: Theravectys S.A.
Sex: All
Age: 18+
Code: NCT06319963
Phase 1, Phase 2, Recruiting
Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia
for
Schizophrenia
Location: Boston MA, Gaithersburg MD, Hollywood FL,
Sponsor: Reviva Pharmaceuticals
Sex: All
Age: 18 - 65
Code: NCT05184335
Phase 3, Recruiting
Interoceptive Mechanisms of Body Image Disturbance in Anorexia Nervosa
for
Anorexia Nervosa, Body Image Disturbance, Interoception
Location: Tulsa OK
Sponsor: Laureate Institute for Brain Research, Inc.
Sex: Female
Age: 13 - 50
Code: NCT06332963
Recruiting
Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder
for
Generalized Anxiety Disorder
Location: Farmington CT, Brooklyn NY, Staten Island NY, Media PA,
Sponsor: Intra-Cellular Therapies, Inc.
Sex: All
Age: 18+
Code: NCT06701903
Phase 2, Recruiting
A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
for
Sickle Cell Disease
Location: Boston MA, Queens NY, The Bronx NY, Brooklyn NY,
Sponsor: Novo Nordisk A/S
Sex: All
Age: 12+
Code: NCT06612268
Phase 3, Recruiting
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Location: New York NY, Staten Island NY, Richmond VA,
Sponsor: Intra-Cellular Therapies, Inc.
Sex: All
Age: 5 - 17
Code: NCT06229210
Phase 3, Recruiting
The Effect of Different Low-Level Tragus Stimulation Parameters On Autonomic Nervous System Function
for
Atrial Fibrillation, Heart Failure, Diastolic
Location: Oklahoma City OK
Sponsor: University of Oklahoma
Sex: All
Age: 21 - 70+
Code: NCT04682704
Recruiting
Protect the Head to Head Study
for
Embolism
Location: New York NY, Tulsa OK
Sponsor: Emboline
Sex: All
Age: 18+
Code: NCT05684146
Phase 2, Recruiting
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
for
Ovarian Cancer, Fallopian Tube Cancer,
Location: Scarborough ME, Providence RI, New Haven CT, Mineola NY,
Sponsor: Merck Sharp & Dohme LLC
Sex: Female
Age: 18+
Code: NCT06824467
Phase 3, Recruiting
Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature
for
Peripheral Vascular Diseases
Location: Boston MA, Providence RI, New Haven CT, New York NY,